Medtronic (MDT) Tops Q1 EPS by 9c, Raises EPS Guidance

Medtronic (NYSE: MDT) reported Q1 EPS of $1.41, $0.09 better than the analyst estimate of $1.32. Revenue for the quarter came in at $7.99 billion versus the consensus estimate of $7.85 billion.

GUIDANCE:

Medtronic sees FY2022 EPS of $5.65-$5.75, versus the consensus of $5.69.

• company continues to expect revenue growth in its fiscal year 2022 to approximate 9% on an organic basis

For earnings history and earnings-related data on Medtronic (MDT) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance